Hyaluronidase injection vs direct surgery in surgical rhinoplasty patients treated with non-surgical nasal reshaping with hyaluronic acid filler: a systematic review

Rauso, Raffaele; Fragola, Romolo; Nicoletti, Giovanni Francesco; Zerbinati, Nicola; Cirillo, Pierfrancesco; Bertossi, Dario; Finocchi, Valerio; Pascali, Michele; Bove, Pierfrancesco; Giudice, Giovanni

doi:10.1007/s00238-021-01916-z

Cited by 1 publication

(1 citation statement)

References 44 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Either direct surgical approach or hyaluronidase injection first seems to be viable options with the total absence of postoperative complications. 44 …”

Section: Discussionmentioning

confidence: 99%

An Italian Online Survey Regarding the Use of Hyaluronidase in Previously Hyaluronic Acid-Injected Noses Looking for Surgical Rhinoplasty

Staglianò

Tartaro

Bertossi

et al. 2022

Aesthetic Surgery Journal Open Forum

Self Cite

View full text Add to dashboard Cite

Background Nonsurgical nasal reshaping (nSNR) with hyaluronic acid (HA) filler is a well-established procedure performed to ameliorate nasal appearance and considered a valid alternative to surgical rhinoplasty in selected patients. Objective The aim of our study is to evaluate the decision-making process and management of patients undergoing rhinoplasty, with previous HA filler injection, and evaluate if consensus could be achieved to recommend guidelines. Methods Between April and May 2021 an on-line survey was sent to 402 Italian surgeons of different specialties. The survey collected information regarding types of treatment of patients who have previously undergone nSNR, who should undergo surgical rhinoplasty. For those surgeons using hyaluronidase an additional information was collected. Results In a range of time of two months (April-May 2021) a total of 72 surgeons replied and completed the survey: out of the 402 questionnaires sent, the response rate was of approximately 18%. The majority of respondent (61,5%) replied to inject hyaluronidase (HYAL) in patients who had to undergo a rhinoplasty but reported previous nSNR. Of the surgeons who use HYAL, 70% performed rhinophasty after a waiting time of 3 to 4 weeks. Conclusions Either direct surgical approach or hyaluronidase injection first seems to be a viable options. The use of HYAL before surgery is the choice with the broadest consensus in our survey. However a larger case-control study with long follow-ups is necessary to understand if in patient seeking surgical rhinoplasty who already received nSNR, the injection of hyaluronidase prior to surgery is mandatory, recommended or not.

show abstract

“…Either direct surgical approach or hyaluronidase injection first seems to be viable options with the total absence of postoperative complications. 44 …”

Section: Discussionmentioning

confidence: 99%